Infographic: Global landscape for RWD and RWE initiatives in regulatory decision making

The global landscape for real-world data (RWD) and real-world evidence (RWE) initiatives in regulatory decision making is rapidly evolving. There is a growing recognition of the value of RWE in supporting regulatory decisions, and a number of regulatory agencies around the world have published guidance on the use of RWE. In this infographic, created by The Evidence Base®, we've pulled together the various initiatives from around the globe, from the latest EMA report on the use of real-world evidence in regulatory decision making, to the FDA’s Real-World Evidence Program and the NMPA guidances from China, to provide our readers with an at-a-glance overview of the field. As the use of RWE becomes more widespread, we can expect to see even more innovative ways to use this type of data to support regulatory decisions so check back regularly for updates. Click on the links within the infographic below to go directly to the resource listed. If you'd like to receive a PDF copy of this infographic, or are interested in sponsoring future infographics across areas of RWE, health economics and outcomes research and market access, please email Phil Garner. [pdf-embedder url="https://www.evidencebaseonline.com/wp-content/uploads/2023/07/Global-landscape-for-RWD-and-RWE-initiatives-in-regulatory-decision-making.pdf" title="Global landscape for RWD and RWE initiatives in regulatory decision making"] You may also be interested in: 1st GetReal Institute Annual Conference: Deep dive into Keynote 2 – Mark McClellan discusses real-world data and evidence in global contexts Rich Gliklich: Can you cast a critical eye on the state of RWE, and tell us from your perspective what are we doing well, and what needs to get better? Evaluating the quality of real-world evidence with a standardized assessment tool: an interview with Ashley Jaksa and Katsiaryna Bykov